cancer therapeutic with early exit potential
- Website
- Company size
- 1-10 people
- Total raised
- $3M
- Company type
- Startup
- Markets
Sialix careers
Sialix is developing two distinct products based on the same discoveries from the Ajit Varki lab at UCSD in glycobiology and cancer.
1) Therapeutic antibodies targeting glycan alterations seen in multiple solid tumors.
2) Anti-inflammatory nutrition products targeting these same cancer-associated glycans found in dietary red meat.
1) Therapeutic antibodies targeting glycan alterations seen in multiple solid tumors.
2) Anti-inflammatory nutrition products targeting these same cancer-associated glycans found in dietary red meat.
Sialix hasn't added any jobs yet
Get notified when Sialix posts new jobs.
Worked at @Biogen Idec, @alnylam • Studied at @Harvard University, @Massachusetts Institute of Technology
Total raised
$3M
Funded over
2 rounds
Latest round
Series B (Feb 2014)
Penumbra • Alameda • 3 weeks ago
Quartzy • United States • 4 days ago